Skip to content

A multi-center, randomized, controlled efficacy evaluation study of Bushen-Follicle-Assisting granules in patients with kidney deficiency in IVF antagonist regimen

A multi-center, randomized, controlled efficacy evaluation study of Bushen-Follicle-Assisting granules in patients with kidney deficiency in IVF antagonist regimen

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070908
Enrollment
Unknown
Registered
2023-04-26
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility(IVF antagonist program)

Interventions

treatment group:Traditional Chinese medicine (kidney supplement granules) + antagonist program to induce ovulation and egg retrieval Kidney supplement granules: uniformly provide no-frying preparation
The dosage form of kidney tonic granules is bagged granules, 1 pack each time, 50ml of fresh boiled water. Duration: 14 days from the 2nd day of the menstrual cycle, 3 times a day, 1 pack at a time.
Control group:antagonist program to induce ovulation and egg retrieval

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Meet the indications for VF/ICSI-ET; (2) IVF/ICSI-ET controlled super-ovulation induction program is an antagonist program; (3) meet the diagnostic criteria for ovarian hyporesponsiveness; (4) Meet the TCM differentiation standards; (5) BMI = 18kg/m2 and <25kg/m2; (6) Voluntarily enter the project and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those with related drug allergies or allergic constitutions; (2) Those suffering from serious primary diseases or serious mental disorders or acute infectious diseases; (3) Genital organ malformations, reproductive system inflammation and tumors; (4) Have a history of serious bad habits or exposure; (5) Those who undergo preimplantation genetic testing cycle; (6) Patients with stage III and IV endometriosis and patients with deep infiltrating endometriosis (DIE);

Design outcomes

Primary

MeasureTime frame
Number of eggs obtained;Egg harvest rate;

Secondary

MeasureTime frame
Optimal embryo rate;Number of embryos that can be transferred;Clinical pregnancy rate of fresh embryo transfer;Early miscarriage rates;

Countries

China

Contacts

Public ContactZeng Qian

Chengdu University of Traditional Chinese Medicine

zqian999d@126.com+86 18981885627

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026